Biomarkers for Acute Graft-versus-host Disease
NCT02254798 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 315
Last updated 2014-10-02
Summary
Validation of already described biomarkers on acute GVHD prediction and severity Fecal calprotectin and alpha 1 anti-trypsin, plasmatic RER3a, IL-8, Elafin, TNFaR1, IL-2R alpha, HGF
Conditions
- Acute GVH Disease
Interventions
- OTHER
-
no intervention
this is a non interventional study
Sponsors & Collaborators
-
Assistance Publique - Hôpitaux de Paris
lead OTHER
Principal Investigators
-
Marie Robin · Hôpital Saint-Louis
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-01-31
- Primary Completion
- 2017-06-30
- Completion
- 2017-12-31
Countries
- France
Study Locations
More Related Trials
-
Establishment of a Strategy for Preventing Graft-versus-host Disease After Allogeneic Hematopoietic Cell Transplantation by Exploring Immune Mechanisms of Regulatory and Effector T Cells
NCT07150468 ·Status: COMPLETED
-
Cell Free DNA Profiling As a Tool to Monitor Clinically-Relevant Events in Allogeneic Hematopoietic Stem Cell Transplantation
NCT06715046 ·Status: RECRUITING
-
Predictive Biomarkers For Pediatric Chronic Graft-Versus-Host Disease
NCT02067832 ·Status: ACTIVE_NOT_RECRUITING
-
Biomarker Study for Prediction of aGVHD
NCT03614143 ·Status: UNKNOWN
-
Immunoregulatory T Lymphocytes Subtypes and Haematopoietic Stem Cell Transplantation (HSCT)
NCT02194868 ·Status: COMPLETED
-
Biomarkers in Predicting Response in Patients With Graft-Versus-Host Disease Undergoing Extracorporeal Photophoresis
NCT01324908 ·Status: TERMINATED ·Phase: NA
-
Biomarker Verification in Pediatric Chronic GvHD: ABLE 2.0 / PTCTC GVH 1901 Study
NCT04372524 ·Status: RECRUITING
-
Early Detection of Graft-Versus-Host Disease in Patients Undergoing a Donor Bone Marrow Transplant
NCT00898612 ·Status: WITHDRAWN
-
Metabolome and Microbiome Impact on Acute GVHD in Recipients of Hematopoietic Transplant
NCT05186857 ·Status: ACTIVE_NOT_RECRUITING
-
Predicting the Quality of Response to Specific Treatments in Patients With cGVHD, PQRST Study
NCT04431479 ·Status: RECRUITING
-
Feasibility Study of Collecting Multicenter Chronic GVHD Data
NCT00506233 ·Status: COMPLETED
-
Improving Outcomes Assessment in Chronic GVHD
NCT00637689 ·Status: ACTIVE_NOT_RECRUITING
-
Analysis of Transcriptomic Profile of Graft-versus-host Disease (GHVD) After Allogeneic Grafting of Hematopoietic Stem Cells
NCT03136757 ·Status: UNKNOWN
-
MicroRNAs as Diagnostic and Predictive Biomarkers for Acute Graft Versus Host Disease
NCT02917148 ·Status: WITHDRAWN
-
Chronic GVHD Response Measures Validation
NCT01902576 ·Status: ACTIVE_NOT_RECRUITING
-
The Skin Microbiome in Graft Versus Host Disease
NCT04231500 ·Status: ACTIVE_NOT_RECRUITING
-
Comparison of Gut Microbiota, Inflammation and Symptoms Following Allogeneic HSCT
NCT02398708 ·Status: COMPLETED
-
Multiparametric Ultrasound Study in Diagnosing GvHD
NCT05790135 ·Status: SUSPENDED ·Phase: NA
-
Donor Neutrophil Subsets to Predict the Risk of aGVHD
NCT06394895 ·Status: ACTIVE_NOT_RECRUITING
-
Bridging Pediatric and Adult Biomarkers in Graft-Versus-Host Disease
NCT02194439 ·Status: COMPLETED
-
The Association of Microbiota Composition With cGVHD After Allo-HSCT
NCT05355675 ·Status: UNKNOWN
-
Kinetic Analysis of Immune Cells in Blood and Chronic Graft-Versus-Host Disease-Affected Tissues After Allogeneic Hematopoietic Cell Transplantation
NCT07235501 ·Status: NOT_YET_RECRUITING
-
Monitoring of Immune and Microbial Reconstitution in (HCT) and Novel Immunotherapies
NCT03557749 ·Status: TERMINATED
-
Inflammatory Response to Paramyxovirus Infection in an Ex-vivo Model of Bronchial Epithelial Cells in Allogeneic HSCT Recipients
NCT03684083 ·Status: UNKNOWN
-
FMT In High-Risk Acute GVHD After ALLO HCT
NCT04139577 ·Status: COMPLETED ·Phase: PHASE1